These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18767956)

  • 1. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM; Draghia-Akli R
    Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
    Stevenson FK; Rice J; Ottensmeier CH; Thirdborough SM; Zhu D
    Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines for cancer.
    Boyd D; Hung CF; Wu TC
    IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current progress of DNA vaccine studies in humans.
    Lu S; Wang S; Grimes-Serrano JM
    Expert Rev Vaccines; 2008 Mar; 7(2):175-91. PubMed ID: 18324888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
    Weide B; Garbe C; Rammensee HG; Pascolo S
    Immunol Lett; 2008 Jan; 115(1):33-42. PubMed ID: 18006079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines: an historical perspective and view to the future.
    Liu MA
    Immunol Rev; 2011 Jan; 239(1):62-84. PubMed ID: 21198665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccination against tumors.
    Prud'homme GJ
    J Gene Med; 2005 Jan; 7(1):3-17. PubMed ID: 15538731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer vaccines: preclinical studies and novel strategies.
    Palena C; Abrams SI; Schlom J; Hodge JW
    Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccines: precision tools for activating effective immunity against cancer.
    Rice J; Ottensmeier CH; Stevenson FK
    Nat Rev Cancer; 2008 Feb; 8(2):108-20. PubMed ID: 18219306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S; Lee JB; Lee GK; Chang J
    Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MG7 mimotope-based DNA vaccination for gastric cancer.
    Zhang D; Chen Y; Fan D
    Expert Rev Vaccines; 2006 Apr; 5(2):223-31. PubMed ID: 16608422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ; Schneider J
    Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA for genetic vaccination and therapy.
    Moelling K
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):127-35. PubMed ID: 9287251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising particle-based vaccines in cancer therapy.
    Xiang SD; Scalzo-Inguanti K; Minigo G; Park A; Hardy CL; Plebanski M
    Expert Rev Vaccines; 2008 Sep; 7(7):1103-19. PubMed ID: 18767957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines for the treatment of prostate cancer.
    Alam S; McNeel DG
    Expert Rev Vaccines; 2010 Jul; 9(7):731-45. PubMed ID: 20624047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus as vehicle for anticancer genetic immunotherapy.
    Gallo P; Dharmapuri S; Cipriani B; Monaci P
    Gene Ther; 2005 Oct; 12 Suppl 1():S84-91. PubMed ID: 16231059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral vector as vaccine carrier.
    Chen WC; Huang L
    Adv Genet; 2005; 54():315-37. PubMed ID: 16096017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical results of vaccine therapy for cancer: learning from history for improving the future.
    Choudhury A; Mosolits S; Kokhaei P; Hansson L; Palma M; Mellstedt H
    Adv Cancer Res; 2006; 95():147-202. PubMed ID: 16860658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.